High content screening identifies monensin as an EMT-selective cytotoxic compound

Marion Vanneste(University of Iowa), Michael D. Henry(University of Iowa)

Scientific Reports

February 4, 2019

10.1038/s41598-018-38019-y

Cited by 45

Related Papers

Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration

|Cell|2002|297

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis

|Frontiers in Oncology|2020|60

A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging

|PLoS ONE|2017|22

Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging

|PLoS ONE|2020|9

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition

|Frontiers in Oncology|2023|7